$18.94
0.894.93%
Last update: Nov 4, 11:44 AM

The average analyst price target for Dyne Therapeutics is $36.95, 95.1% above the current price. Of 17 analysts, 15 rate it Buy, 1 Hold and 1 Sell. Targets range from $10 to $56. The latest change came on Oct 28, 2026, when Oppenheimer downgraded Dyne Therapeutics from Outperform to Perform and moved its price target from $40 to $15.
Price Target Range — 12 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months